AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2025
Nov 12, 2025
31801_dirs_2025-11-12_c171289d-26e6-434b-8be2-34a419b74551.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2025-11-10
Reporting Person: Lawver Teri L (N/A)
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Capital/Financing Update
2026
Apr 2
Capital/Financing Update
2026
Apr 1
Major Shareholding Notification
2026
Mar 26